Pharma News

Keep updating your pharma knowledge
16 Sep 2016

Allergan to acquire Vitae Pharma

Posted By

Allergan, the maker of Botox, will Vitae Pharmaceuticals, a drugmaker focused on dermatology segment at $639 million (€567 million).
Vitae is developing an experimental drug for psoriasis, an autoimmune skin disease, and another medicine for atopic dermatitis, which causes itching and inflammation. The drugs are in mid-stage clinical testing.

This deal will help allergan to errich dermatology pipeline.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!